CYTOSORBENTS CORP (CTSO)
US23283X2062 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 43.17M 5.29% | 34.69M -19.64% | 36.349M 4.78% | 39.287M 8.08% | 44.316M 12.80% | 53.965M 21.77% | 65.885M 22.09% | 125.34M 90.24% | 211.55M 68.78% | 283.72M 34.11% | 349.7M 23.26% | |
| EBITDA YoY % growth | -22.01M -126.67% | -30.64M -39.21% | -28.811M 5.97% | -14.96M 48.07% | -5.552M 62.89% | 3.729M 167.17% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -22.74M -119.29% | -31.52M -38.61% | -30.273M 3.96% | -16.613M 45.12% | -12.362M 25.59% | -5.619M 54.54% | -3.334M 40.67% | 39.114M 1,273.23% | 105.27M 169.14% | 157.81M 49.91% | 205.49M 30.21% | |
| Operating Margin | -52.68% | -90.86% | -83.28% | -42.29% | -27.89% | -10.41% | -5.06% | 31.21% | 49.76% | 55.62% | 58.76% | |
| EPS YoY % growth | -0.57 -185.00% | -0.76 -33.33% | -0.65 14.47% | -0.31 52.92% | -0.21 32.22% | -0.09 57.37% | -0.15 -73.07% | N/A | N/A | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.07 47.69% | -0.07 44.75% | -0.06 29.87% | -0.06 -40.25% | -0.06 17.50% |
| Revenue Q2Q % growth | 10.03M 15.71% | 10.29M 5.15% | 10.728M 8.42% | 11.599M 23.52% | 12.035M 19.99% |
| EBITDA Q2Q % growth | -3.171M 57.26% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.827M 56.91% | -4.476M 7.93% | -4.668M -44.33% | -5.058M -16.76% | -5.253M -37.26% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.04 80.95% | -0.06 | 0.02 | 38.08% |
| Q2 2024 Q2Q % growth | -0.08 42.86% | -0.10 | 0.02 | 19.56% |
| Q1 2024 Q2Q % growth | -0.12 29.41% | -0.12 | 0.00 | 1.96% |
| Q4 2023 Q2Q % growth | -0.13 -550.00% | -0.14 | 0.01 | 7.31% |
| Q3 2023 Q2Q % growth | -0.21 25.00% | -0.14 | -0.07 | -49.19% |
| Q2 2023 Q2Q % growth | -0.14 44.00% | -0.11 | -0.03 | -22.00% |
| Q1 2023 Q2Q % growth | -0.17 19.05% | -0.13 | -0.04 | -31.58% |
| Q4 2022 Q2Q % growth | -0.02 90.48% | -0.17 | 0.15 | 88.33% |
| Q3 2022 Q2Q % growth | -0.28 -86.67% | -0.17 | -0.11 | -67.38% |
| Q2 2022 Q2Q % growth | -0.25 -127.27% | -0.14 | -0.11 | -83.25% |
| Q1 2022 Q2Q % growth | -0.21 -110.00% | -0.12 | -0.09 | -68.07% |
| Q4 2021 Q2Q % growth | -0.21 | -0.14 | -0.07 | -55.50% |
| Q3 2021 Q2Q % growth | -0.15 -650.00% | -0.12 | -0.03 | -20.87% |
| Q2 2021 Q2Q % growth | -0.11 -37.50% | -0.04 | -0.07 | -175.53% |
| Q1 2021 Q2Q % growth | -0.10 | -0.03 | -0.07 | -194.15% |
| Q4 2020 Q2Q % growth | 0.00 100.00% | -0.04 | 0.04 | 100.00% |
| Q3 2020 Q2Q % growth | -0.02 90.48% | -0.09 | 0.07 | 78.33% |
| Q2 2020 Q2Q % growth | -0.08 27.27% | -0.08 | 0.00 | -0.13% |
| Q1 2020 Q2Q % growth | -0.10 33.33% | -0.14 | 0.04 | 27.38% |
| Q4 2019 Q2Q % growth | -0.12 | -0.17 | 0.05 | 28.26% |
| Q3 2019 Q2Q % growth | -0.21 | -0.14 | -0.07 | -53.64% |
| Q2 2019 Q2Q % growth | -0.11 | -0.15 | 0.04 | 25.11% |
| Q1 2019 Q2Q % growth | -0.15 | -0.18 | 0.03 | 18.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 9.39M 6.58% | 10.385M | -994.61K | -9.58% |
| Q2 2024 Q2Q % growth | 9.895M 5.03% | 9.871M | 23.64K | 0.24% |
| Q1 2024 Q2Q % growth | 9.786M 3.56% | 9.98M | -193.71K | -1.94% |
| Q4 2023 Q2Q % growth | 8.668M -7.69% | 9.471M | -803K | -8.48% |
| Q3 2023 Q2Q % growth | 8.811M 8.64% | 9.461M | -650K | -6.87% |
| Q2 2023 Q2Q % growth | 9.421M 10.83% | 11.247M | -1.826M | -16.24% |
| Q1 2023 Q2Q % growth | 9.45M 8.74% | 8.908M | 541.5K | 6.08% |
| Q4 2022 Q2Q % growth | 9.39M -12.89% | 8.899M | 491K | 5.52% |
| Q3 2022 Q2Q % growth | 8.11M -16.91% | 9.159M | -1.049M | -11.45% |
| Q2 2022 Q2Q % growth | 8.5M -29.28% | 9.767M | -1.267M | -12.97% |
| Q1 2022 Q2Q % growth | 8.69M -18.02% | 9.922M | -1.232M | -12.42% |
| Q4 2021 Q2Q % growth | 10.78M -9.87% | 10.309M | 471K | 4.57% |
| Q3 2021 Q2Q % growth | 9.76M -7.49% | 11.243M | -1.483M | -13.19% |
| Q2 2021 Q2Q % growth | 12.02M 22.78% | 12.514M | -494K | -3.95% |
| Q1 2021 Q2Q % growth | 10.6M 21.70% | 11.734M | -1.134M | -9.66% |
| Q4 2020 Q2Q % growth | 11.96M 60.97% | 11.166M | 794K | 7.11% |
| Q3 2020 Q2Q % growth | 10.55M 72.95% | 9.705M | 845K | 8.71% |
| Q2 2020 Q2Q % growth | 9.79M 57.14% | 9.781M | 9K | 0.09% |
| Q1 2020 Q2Q % growth | 8.71M 67.82% | 7.145M | 1.565M | 21.90% |
| Q4 2019 Q2Q % growth | 7.43M | 6.942M | 488K | 7.03% |
| Q3 2019 Q2Q % growth | 6.1M | 6.795M | -695K | -10.23% |
| Q2 2019 Q2Q % growth | 6.23M | 6.234M | -4K | -0.06% |
| Q1 2019 Q2Q % growth | 5.19M | 6.298M | -1.108M | -17.59% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 13.04% | 0% | 6.98% |
| Revenue | 0% | -2.49% | 0% | -2.75% |